Article Rich – Lifestyle

Author: PineTree Therapeutics

Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca

April 29, 2026

All content ©2025 Tork Media
All Rights Reserved. For more information on this site, please read our Privacy Policy, Terms of Service, Cookie Policy, and Ad Choices.